TARO PHARMACEUTICAL INDUSTRIES LTD. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 42.4 USD | -0.04% |
|
+0.18% | +1.50% |
| 20/05 | Taro Pharmaceutical Industries Fiscal Q4 Earnings, Revenue Rise | MT |
| 20/05 | Earnings Flash (TARO) TARO PHARMACEUTICAL INDUSTRIES Reports Q4 Revenue $164.9M, vs. Street Est of $156.1M | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 1.59B | - | - | - | - | ||
| 705B | ||||||
| 583B | ||||||
| 364B | ||||||
| 332B | ||||||
| 291B |
